ProTecs and Fraunhofer Advance Vaccine Manufacturing in Delaware

NEWARK, Del.--(BUSINESS WIRE)--The Fraunhofer USA Center for Molecular Biotechnology, a not-for-profit, 501 (c3) research organization, announced today that it has received a $60,000 gift from ProTecs, Inc., to complete its new, state of-the-art vaccine manufacturing plant in Newark, Delaware.

Back to news